IP Library Granted Patent US 8,047,651
Granted Patent B2
US 8,047,651 · App. 12/860,701 · Granted Nov 1, 2011

Electro-active opthalmic lens having an optical power blending region

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,047,651
App. No.
12/860,701
Granted
Nov 1, 2011
Kind
B2
Abstract

A spectacle lens is disclosed. The disclosed lens provides a vision correcting area for the correction of a wearer's refractive error. The viewing correction area provides correction for non-conventional refractive error to provide at least a part of the wearer's vision correction. The lens has a prescription based on a wave front analysis of the wearer's eye and the lens can further be modified to fit within an eyeglass frame.

Claims (23)

1. A method of programming an electro-active spectacle comprising:

programming a prescription based on a conventional refractive error into a controller that controls an electro-active lens;

measuring a non-conventional refractive error of a patient's eye using either an autorefractor or a wavefront analyzer, while the patient is looking through the electro-active lens, and while the electro-active lens is controlled to correct for the prescription;

refining of the prescription by:

accounting for the non-conventional refractive error measured while the patient is looking through the electro-active lens while the electro-active lens is controlled to correct for the prescription;

programming the electro-active spectacle with the refined prescription.

2. The method of claim 1 , further comprising dispensing the electro-active spectacle to the patient.

3. The method of claim 1 , further comprising determining the conventional refractive error programmed into the controller that controls the electro-active lens by measuring the conventional refractive error of the patient's eye using a refractor.

4. The method of claim 3 , wherein the refractor used to measure the conventional refractive error is a conventional refractor, an electro-active refractor, or an autorefractor.

5. The method of claim 1 , further comprising:

measuring a non-conventional refractive error of a patient's eye using either an autorefractor or a wavefront analyzer, while the patient is looking through the electro-active lens, and while the electro-active lens is controlled to correct for the refined prescription;

further refining of the refined prescription by:

accounting for the non-conventional refractive error measured while the patient is looking through the electro-active lens, while the electro-active lens is controlled to correct for the refined prescription.

6. The method of claim 1 , comprising further refining the prescription via the patient using a control unit.

7. The method of claim 1 , comprising further refining the prescription via an eye care professional using a control unit.

8. The method of claim 1 , wherein the controller is read-only.

9. The method of claim 1 , wherein the controller is reprogrammable.

10. The method of claim 1 , wherein the controller is an ASIC.

11. The method of claim 1 , wherein the controller is an FPGA.

12. The method of claim 1 , wherein the refined prescription programmed into the electro-active spectacle improves the patient's visual acuity to better than 20/20.

13. The method of claim 1 , wherein the non-conventional refractive error is due to an irregular astigmatism.

14. The method of claim 1 , wherein the non-conventional refractive error is due to ocular refractive irregularities.

15. The method of claim 1 , wherein the non-conventional refractive error is due to aqueous irregularities.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2023
From: E-VISION, LLC
To: E-VISION OPTICS, LLC
Reel/Frame 065629/0772 →